The 2024 MIT Houston Symposium will gain the insights needed to navigate the dramatic changes driven by global economic forces, emerging technologies, and evolving government policies. This event will explore the transformative power of artificial intelligence (AI), essential workforce development strategies, groundbreaking advancements in manufacturing, shifting international trade patterns, and the impact of recent U.S. legislation on industrial policy.
Please visit the MIT ILP site for the full agenda.
MIT Startup Exchange is looking for 8-12 startups (in IoT, advanced manufacturing, energy, materials, life science & medical devices) to speak at MIT ILP's annual Wuxi Symposium, held virtually on Zoom evening of Wed. Jan. 27th (Jan. 28th Beijing time).
Wise Systems: AI-driven platform to optimize fleet-wide efficiency James Agan, Product Marketing Manager, Wise Systems
DUST Identity: Linking objects to digital records to solve complex supply chain security needs Ophir Gaathon, CEO & Co-Founder, DUST Identity
Aulera: Create and Leverage Digital Identities for Physical Products Nathan Stempel, CFO & Co-founder, Aulera
Colvin Run Networks: Defense-grade assurance and analytics solutions Michael McComas, VP of Innovation, Colvin Run Networks
SourceTrace: Agri-Food digital solutions for sustainable farming and efficient, transparent and traceable supply chains Venkat Maroju, CEO, SourceTrace
Lightning Talk
Rich Bavasso CEO and Co-Founder, nQ Medical Nader Yaghoubi President and CEO, PathMaker Neurosystems Bobby Brooke Herrera Co-founder & Interim CEO, E25Bio Thanos Kosmidis Co-Founder & CEO, CareAcross Drew Arenth macro-eyes Zen Chu Senior Lecturer, MIT Sloan Jon Bloom Co-Founder and CEO, Podimetricsl Nigel Surridge Research Fellow, Roche Diabetes Care Inc. Antonio Melo Vice President, Digital Experience Center, , Humana Digital Health Analytics Anne Kim Cofounder & CEO, Secure AI Labs (SAIL) Brandon Busuito Founder & CEO, CoVerified Sam Shames Embr Labs
Evonik wants to experience new innovative ideas to broaden the application field of VESTENAMER® and enter new markets with this product.
Elbit is looking to provide goodwill help in the near term to MIT Startups on COVID-19 related efforts including medical devices design, prototyping, manufacturing, and engineering support. 20% of Elbit's business is in medical equipment, and can also help advice startups on readying their offering for FDA approval. MIT Startups are invited to apply for Zoom Meeting with Elbit’s Director of Research and Development,